Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Westervelt

Showing results (271-280 of 359) with videos related to

Pageof 36
Sort By:
Leukemia|July 27, 2017
Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trialD J DeAngelo, T I George, A Linder, et al.
American Journal of Hematology|October 7, 2009
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSFMike G Martin, Kristan M Augustin, Geoffrey L Uy, et al.
Nature|February 5, 2025
Superfluid stiffness of twisted trilayer graphene superconductorsAbhishek Banerjee, Zeyu Hao, Mary Kreidel, et al.
Pain Medicine (Malden, Mass.)|December 14, 2020
Responding to the Opioid Epidemic: Educational Competencies for Pain and Substance Use Disorder from the Medical Schools of the University of CaliforniaMark Servis, Scott M Fishman, Mark S Wallace, et al.
Environmental Science & Technology|March 25, 2025
Low-Cost PM<sub>2.5</sub> Sensor Performance Characteristics against Meteorological Influence in Sub-Saharan Africa: Evidence from the Air Sensor Evaluation and Training Facility for the West Africa ProjectJames Nimo, Mathias A Borketey, Emmanuel K-E Appoh, et al.
Leukemia|March 19, 2011
Recurrent DNMT3A mutations in patients with myelodysplastic syndromesM J Walter, L Ding, D Shen, et al.
JCO Oncology Practice|January 23, 2024
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102Wael Saber, Aasthaa Bansal, Lily Li, et al.
Blood Cancer Discovery|January 12, 2022
Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid LeukemiaAllegra A Petti, Saad M Khan, Ziheng Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 15, 2013
Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimenShivaprasad Manjappa, Pavan Kumar Bhamidipati, Keith E Stokerl-Goldstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 StudyJurjen Versluis, Wael Saber, Harrison K Tsai, et al.
Pageof 36

Showing results (271-280 of 359) with videos related to

Sort By:
Pageof 36
Leukemia|July 27, 2017
Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trialD J DeAngelo, T I George, A Linder, et al.
American Journal of Hematology|October 7, 2009
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSFMike G Martin, Kristan M Augustin, Geoffrey L Uy, et al.
Nature|February 5, 2025
Superfluid stiffness of twisted trilayer graphene superconductorsAbhishek Banerjee, Zeyu Hao, Mary Kreidel, et al.
Pain Medicine (Malden, Mass.)|December 14, 2020
Responding to the Opioid Epidemic: Educational Competencies for Pain and Substance Use Disorder from the Medical Schools of the University of CaliforniaMark Servis, Scott M Fishman, Mark S Wallace, et al.
Environmental Science & Technology|March 25, 2025
Low-Cost PM<sub>2.5</sub> Sensor Performance Characteristics against Meteorological Influence in Sub-Saharan Africa: Evidence from the Air Sensor Evaluation and Training Facility for the West Africa ProjectJames Nimo, Mathias A Borketey, Emmanuel K-E Appoh, et al.
Leukemia|March 19, 2011
Recurrent DNMT3A mutations in patients with myelodysplastic syndromesM J Walter, L Ding, D Shen, et al.
JCO Oncology Practice|January 23, 2024
Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome: Analysis of BMT CTN 1102Wael Saber, Aasthaa Bansal, Lily Li, et al.
Blood Cancer Discovery|January 12, 2022
Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid LeukemiaAllegra A Petti, Saad M Khan, Ziheng Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 15, 2013
Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimenShivaprasad Manjappa, Pavan Kumar Bhamidipati, Keith E Stokerl-Goldstein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 StudyJurjen Versluis, Wael Saber, Harrison K Tsai, et al.
Pageof 36